NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Front Line Medical Technologies

Front Line Medical Technologies

Private
LondonHealthcare & Life Scienceshttps://frontlinemedtech.com/

Last Round

Grant

Dec 20, 2020

Total Funding Raised

$162,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Front Line Medical Technologies is a medical devices and equipment company that develops the COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System), a life-saving device for controlling hemorrhage in emergency and trauma situations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

hemorrhage controlaortic occlusion deviceREBOAREBOA cathetertrauma careemergency medicinemilitary medicinebattlefield medicinestop the bleedResuscitative Endovascular Balloon Occlusion of the Aortamedical devicearterial occlusionlow-profile catheternon-compressible torso hemorrhageNCTHpre-hospital caretactical medicineTCCC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Front Line Medical Technologies Comparables

Compare Front Line Medical Technologies with similar companies based on industry and business-model similarity.

Front Line Medical Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prytime Medical Devices, Inc.
92%
Emergency Scientific
88%
Neurescue
84%

Front Line Medical Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 20, 2020
SeedDec 14, 2018

Key People

Founding team and executive leadership

Asha Parekh

Co-Founder and CEO

Founding Team

Front Line Medical Technologies Investors

Notable investors and investment history

Front Line Medical Technologies investors
InvestorRounds
National Research Council Canada Industrial Research Assistance ProgramGrant
VERGE CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 146% MoM, reaching 4.1K.

  • Jan 31, 2026

    Monthly visitors grew 144% MoM, reaching 1.1K.

Front Line Medical Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Front Line Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Front Line Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2017
Last FundingDec 20, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.